Part 1. Summary
Part 2. Introduction
· Study period
· Geographical scope
· Market segmentation
Part 3. Women’s health therapeutics market overview
Part 4. Market breakdown by indication
· Breast cancer
· Endometriosis
· Menopause
· Polycystic ovary syndrome (PCOS)
· Postmenopausal osteoporosis
Part 5. Market breakdown by region
· Asia Pacific
· Europe
· North America
· Rest of the World (RoW)
Part 6. Key companies
· AbbVie Inc.
· Amgen Inc.
· AstraZeneca plc
· Bayer AG
· Daiichi Sankyo Company, Limited
· Eli Lilly and Company
· F. Hoffmann-La Roche AG
· Gilead Sciences, Inc.
· Johnson & Johnson
· Merck KGaA
· Novartis AG
· Novo Nordisk A/S
· Pfizer Inc.
· Sanofi S.A.
· The Bristol-Myers Squibb Company (BMS)
Part 7. Methodology